Meeting the current and future challenges of oncology drug development
This breakout session highlighted four distinct perspectives from leading individuals within patient advocacy, industry, an appraisal committee and physicians on the future and challenges faced by targeted therapy in HTA evaluation. Bringing together leaders from key stakeholders in the process, it...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Cancer Intelligence
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025498/ |